PPC
JAZZ icon

Park Place Capital’s Jazz Pharmaceuticals JAZZ Stock Holding History

Park Place Capital’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.7K Sell
94
-2
-2% -$438 ﹤0.01% 633
2026
Q1 		$18.1K Sell
96
-8
-8% -$1.4K ﹤0.01% 504
2025
Q4 		$17.7K Sell
104
-5
-5% -$767 ﹤0.01% 476
2025
Q3 		$14.4K Buy
109
+13
+14% +$1.56K ﹤0.01% 499
2025
Q2 		$10.5K Hold
96
– – ﹤0.01% 578
2025
Q1 		$11.9K Buy
96
+83
+638% +$10.8K ﹤0.01% 546
2024
Q4 		$1.6K Hold
13
– – ﹤0.01% 751
2024
Q3 		$1.45K Sell
13
-60
-82% -$6.58K ﹤0.01% 805
2024
Q2 		$7.79K Sell
73
-21
-22% -$2.31K ﹤0.01% 647
2024
Q1 		$11.3K Sell
94
-3
-3% -$367 ﹤0.01% 627
2023
Q4 		$11.9K Buy
97
+8
+9% +$998 ﹤0.01% 603
2023
Q3 		$11.5K Hold
89
– – ﹤0.01% 735
2023
Q2 		$11K Hold
89
– – ﹤0.01% 756
2023
Q1 		$13K Sell
89
-11
-11% -$1.63K ﹤0.01% 715
2022
Q4 		$16K Buy
+100
New +$14.7K ﹤0.01% 691

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Park Place Capital's JAZZ Position: Q2 2026 in Review

Park Place Capital reduced its Jazz Pharmaceuticals (JAZZ) stake by 2.1% in Q2 2026, selling an estimated $438 and leaving 94 shares worth $22.7K. The position accounts for ﹤0.01% of the portfolio, ranked #633.

Park Place Capital first reported a position in JAZZ in Q4 2022 and has held it in 15 quarters since. 646 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

  • Park Place Capital held 94 shares of Jazz Pharmaceuticals worth $22.7K as of Q2 2026.
  • Park Place Capital sold 2 Jazz Pharmaceuticals shares in Q2 2026, an estimated $438.
  • Jazz Pharmaceuticals made up ﹤0.01% of Park Place Capital's portfolio in Q2 2026, its #633 holding.
  • Park Place Capital first reported a position in Jazz Pharmaceuticals in Q4 2022 and has held it in 15 quarters since.
  • 646 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Park Place Capital's 13F filing for Q2 2026, filed 14 Aug 2026.